BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19146906)

  • 1. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.
    Zhang Q; Su X; Seto D; Zheng BJ; Tian X; Sheng H; Li H; Wang Y; Zhou R
    Vaccine; 2009 Feb; 27(8):1145-53. PubMed ID: 19146906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant replication-defective human adenovirus type 3: a vaccine candidate.
    Li H; Zhou R; Chen J; Tian X; Zhang Q; Zeng Q; Gong S
    Vaccine; 2009 Jan; 27(1):116-22. PubMed ID: 18977265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus.
    Phillpotts RJ; O'brien L; Appleton RE; Carr S; Bennett A
    Vaccine; 2005 Feb; 23(13):1615-23. PubMed ID: 15694514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate.
    Mayr GA; Chinsangaram J; Grubman MJ
    Virology; 1999 Oct; 263(2):496-506. PubMed ID: 10544121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and characterization of E3-deleted bovine adenovirus type 3 expressing full-length and truncated form of bovine herpesvirus type 1 glycoprotein gD.
    Zakhartchouk AN; Reddy PS; Baxi M; Baca-Estrada ME; Mehtali M; Babiuk LA; Tikoo SK
    Virology; 1998 Oct; 250(1):220-9. PubMed ID: 9770436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of the main structural antigen VP6 of human rotavirus by recombinant adenovirus and immune responses induced in vivo].
    He J; Wang J; Jiang X; Wang D; Wen L; Dong J; Qu J; Hong T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):109-13. PubMed ID: 12196818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells.
    Ambriović A; Adam M; Monteil M; Paulin D; Eloit M
    Virology; 1997 Nov; 238(2):327-35. PubMed ID: 9400605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete protection of mice against a lethal dose challenge of western equine encephalitis virus after immunization with an adenovirus-vectored vaccine.
    Wu JQ; Barabé ND; Chau D; Wong C; Rayner GR; Hu WG; Nagata LP
    Vaccine; 2007 May; 25(22):4368-75. PubMed ID: 17467858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of humoral and cellular immune responses against the nucleocapsid of bovine viral diarrhea virus by an adenovirus vector with an inducible promoter.
    Elahi SM; Shen SH; Talbot BG; Massie B; Harpin S; Elazhary Y
    Virology; 1999 Aug; 261(1):1-7. PubMed ID: 10441551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
    Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
    Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy.
    Moffatt S; Hays J; HogenEsch H; Mittal SK
    Virology; 2000 Jun; 272(1):159-67. PubMed ID: 10873758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a vaccine vector based on a subgenomic replicon of porcine reproductive and respiratory syndrome virus.
    Huang Q; Yao Q; Fan H; Xiao S; Si Y; Chen H
    J Virol Methods; 2009 Sep; 160(1-2):22-8. PubMed ID: 19464739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant.
    Xiang ZQ; Pasquini S; Ertl HC
    J Immunol; 1999 Jun; 162(11):6716-23. PubMed ID: 10352290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction and the immunogenicity of the recombinant Modified Vaccinia Virus Ankala co-expressing ORF4, ORF5 and ORF6 genes of porcine reproductive and Respiratory Syndrome Virus NJ-a strain].
    Zheng QS; Bi ZX; Li P; Chen DS; Chen PY
    Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):345-9. PubMed ID: 17552247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular inoculation of calves with an experimental Newcastle disease virus-based vector vaccine elicits neutralizing antibodies against Rift Valley fever virus.
    Kortekaas J; Dekker A; de Boer SM; Weerdmeester K; Vloet RP; de Wit AA; Peeters BP; Moormann RJ
    Vaccine; 2010 Mar; 28(11):2271-6. PubMed ID: 20079874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of systemic and mucosal immune responses in cotton rats immunized with human adenovirus type 5 recombinants expressing the full and truncated forms of bovine herpesvirus type 1 glycoprotein gD.
    Mittal SK; Papp Z; Tikoo SK; Baca-Estrada ME; Yoo D; Benko M; Babiuk LA
    Virology; 1996 Aug; 222(2):299-309. PubMed ID: 8806514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of the recombinant adenovirus expressing the C-terminal of the Mycoplasma hyopneumoniae p97 gene and its immune response].
    Chen C; Li Y; Guo D; Cao P; Zhang M; Jiang H; Qiao Z; Wang L; Xin J
    Wei Sheng Wu Xue Bao; 2009 Apr; 49(4):465-70. PubMed ID: 19621633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of a non-essential region for replication of fowl adenovirus QU strain].
    Sun J; Li Q; Li Y; Huang B; Song M; Li X
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1263-7. PubMed ID: 18837406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.